Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 17 Dec 2008 |
| Genmab's Financial Calendar for 2009 | 10 Dec 2008 |
| Arzerra(TM) (Ofatumumab) Demonstrates High Response Rates in Patients with Fludarabine Refractory Chronic Lymphocytic Leukaemia (CLL) | 8 Dec 2008 |
| Genmab's Total Number of Voting Rights and Total Share Capital | 28 Nov 2008 |
| Genmab to Present at 2008 Piper Jaffray Health Care Conference | 24 Nov 2008 |